Blog
Why Did the FDA Approve Biogen's Alzheimer's Disease Drug After an Advisory Panel Recommended Against It?
Biogen (NASDAQ: BIIB) recently won U.S. Food and Drug Administration (FDA) approval for its Alzheimer's disease drug Aduhelm. This decision was quite controversial, however, especially considering
4 Income Sources That'll Make You Richer Than Social Security
Social Security pays the typical senior $1,543 a month, but it's possible to get more money out of the program. In fact, the maximum benefit you can collect this year is an impressive $3,895 a month
Next Market Crash 101: 2 Top Growth Stocks to Buy Right Now
The state of the stock market in recent weeks hasn't been for the faint of heart. Whether the volatility investors are currently seeing actually foreshadows another market crash is anyone's guess
This Under-the-Radar Payments Company Could Be a Great Investment
The financial sector is constantly evolving -- especially the payments industry, which is home to countless new companies that are trying to change the way consumers trade with merchants. But some
Here's Why Wells Fargo Needs to Execute on Its New Revenue Opportunities
When you look at the long list of improvements Wells Fargo (NYSE: WFC) has planned, it's clear that the bank's No. 1 priority is getting out from under the $1.95 trillion asset cap that's hindered
12 Words From CureVac's CEO That Could Mean Billions for Moderna and Pfizer
Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) aren't the only mRNA coronavirus vaccine makers in town. In fact, another company has been gaining ground -- and reported pivotal trial results this
Buy This Undervalued Stock Before Everyone Else Does
It's not often you can point to a stock with a valuation roughly twice the broader S&P 500 index and call it undervalued. It makes more sense when the company has grown revenue and profits by 300%
2 Incredibly Cheap Healthcare Stocks
After the S&P 500's nearly 38% rise over the last 12 months, there aren't a lot of investing gurus out there calling the stock market cheap. There are different theories as to what has been driving
A Busy Investor's Guide to Saving Time and Making Money
Investing intimidated me for a long time because I thought you needed to spend hours researching stocks in order to do it well. I didn't have the time -- nor the interest, frankly -- to do that when
The Most Important of Moderna's 3 Catalysts Last Week
Moderna (NASDAQ: MRNA) has been quite busy. The company announced three positive developments last week, all of which have the potential to boost sales for its COVID-19 vaccine. In this Motley Fool
3 Under-the-Radar Stocks That Can Go to the Moon
Although there are more than six months left in 2021, there's little question that this will be remembered as the year retail investors shook Wall Street to its core.
Beginning in January, retail
How Does Novavax Stack Up Against Today's Vaccine Leaders?
Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) have remained a step ahead of most potential coronavirus vaccine rivals. That's thanks to their products' overall efficacy of more than 90%. But one
Where to Invest $500 Right Now
There's a lot you can do with $500, including turning it into $5,000. Don't believe me? If you would have invested $500 in Amazon (NASDAQ: AMZN) stock in 2014, you'd have $5,000 today. And if you
3 Reasons I'm Not Worried About a Stock Market Crash
Are you worried that a stock market crash is coming? It's the million-dollar question that you may have been asking yourself for a while. We're 12 years into the longest-running bull market and
2 Dividend Stocks to Buy Hand Over Fist Right Now
Sure, stocks don't always deliver their strongest growth during the summer months. There's a reason why the old adage to "sell in May then go away" became well known, even if it isn't necessarily
3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%
Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.
However, what goes up can come down
The Smartest Stocks to Buy With $100 Right Now
Over the past 16 months, investors young and old have been given a firsthand lesson in patience. Despite the benchmark S&P 500 losing more than a third of its value in roughly a month last year
Why It's Often Best to Sell Options and Not Buy Them
Investing using options is very different from constructing a classic long-term buy-and-hold portfolio.
In this segment from Motley Fool Live that first aired June 7, Motley Fool Canada analyst Jim
3 Big Investing Mistakes to Avoid in Your 50s
Your 50s are an interesting period of time. On the one hand, if you're aiming to retire in your mid-to-late 60s, it means you're almost close enough to start counting down to that milestone. On the
Why BioNTech, Moderna, and Novavax Stocks Sank This Week
This week hasn't been a great one for COVID-19 vaccine stocks. Shares of BioNTech (NASDAQ: BNTX) were down 10.2% for the week, as of the market close on Thursday. Moderna (NASDAQ: MRNA) stock fell
What Not to Do as a Beginning Options Investor
Investing using options is very different from constructing a classic long-term buy-and-hold portfolio.
In this segment from Motley Fool Live that first aired June 7, Motley Fool Canada analyst Jim
The Riskiest Thing You Can Do With Your Retirement Savings
Sparing any money for retirement savings is a challenge, but that's only half the battle. You also have to decide where you're going to house that money so it can grow over time without exposing you
Why AMC Stock Popped But Express and Alcoa Stocks Dropped This Week
It was a tale of two Reddits on Wall Street this week: Meme-stock investors drove shares of AMC Entertainment Holdings (NYSE: AMC) ever higher -- up 22.9%. But they drove shares of Express (NYSE:
Smith & Wesson Brands, Inc. (SWBI) Q4 2021 Earnings Call Transcript
Image source: The Motley Fool.
Smith & Wesson Brands, Inc. (NASDAQ: SWBI)Q4 2021 Earnings CallJun 17, 2021, 5:00 p.m. ET
Operator
Source Fool.com
Why AMC Stock Popped 10% Today
After what has become an increasingly rare down day for AMC Entertainment (NYSE: AMC) stock yesterday, Thursday's session saw a rebound in the popular meme stock. After dropping 6.5% Wednesday, AMC


